Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Aurobindo Pharma Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

25 Jun 2016 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - Aurobindo Pharma Ltd (AUROPHARMA-IN)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

26 Jun 2016 Thomson Reuters Stock Report 11 $25.00

Aurobindo Pharma Ltd (AUROPHARMA) - Financial Analysis Review

Aurobindo Pharma Ltd (AUROPHARMA) - Financial Analysis Review Summary Aurobindo Pharma Ltd (Aurobindo Pharma) is a pharmaceut...

17 Jun 2016 GlobalData 57 $300.00

Wright Investors Service Comprehensive Report for Aurobindo Pharma Ltd

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

04 Jun 2016 Wright Reports 60 $75.00

MOSL: AUROBINDO PHARMA 4QFY16 (Buy)-Results in line with estimates-US business’ growth momentum to continue

AUROBINDO PHARMA 4QFY16: Results in line with estimates; US business’ growth momentum to continue (ARBP IN, Mkt Cap USD6.8b,...

01 Jun 2016 Motilal Oswal Securities Ltd. 12 $115.00

Aurobindo Pharma (ARBP)_Q4FY16 Result Update

Aurobindo Pharma’s (ARBP) financial performance for Q4FY16 was marginally below our estimates. Net sales increased by 17% y-y...

01 Jun 2016 IndiaNivesh Securities Pvt Ltd 7 $69.00

Spark Capital: 4QFY16 outlook review of Aurobindo Pharma (Rating: BUY, TP: Rs. 902)

4QFY16 outlook review of Aurobindo Pharma (Rating: BUY, TP: Rs. 902) How does our one year outlook change? We maintain ...

01 Jun 2016 Spark Capital Advisors(India) Private Limited 6 $46.00

Aurobindo Pharma Ltd_Q4FY16 Result Flash Note

At CMP Rs.768 the stock is trading at P/E multiple of 17.2x FY17E and 15.0x FY18E estimates. We have BUY with TP of Rs.880 on...

31 May 2016 IndiaNivesh Securities Pvt Ltd 2 $12.00

Aurobindo Pharma (ARBP) - Qtr. Update - Dated - May 31, 2016

Aurobindo Pharma (Bloomberg: ARBP IN, BUY, TP: Rs 1,000; 33% upside from CMP of Rs 754) Aurobindo’s (ARBP) 39% YoY growth ...

31 May 2016 Axis Capital Limited 8 $81.00

Thomson Reuters Stock Report - Aurobindo Pharma Ltd (AUROPHARMA-IN)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

10 May 2016 Thomson Reuters Stock Report 11 $25.00